Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Cue Biopharma, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 75 | 80 | +5 |
| Shares | 14.0M | 14.9M | +871.7K (+6.2%) |
| Value | $32.1M | $39.3M | +$7.16M (+22.3%) |
New holders (11)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 54,629 | $144.2K | 0.00% |
| Occudo Quantitative Strategies LP | 33,439 | $88.3K | 0.01% |
| Navalign, LLC | 25,000 | $66.0K | 0.02% |
| Gsa Capital Partners LLP | 13,952 | $37.0K | 0.00% |
| Legacy Capital Group California, Inc. | 10,000 | $26.4K | 0.01% |
| Comerica Bank | 1,473 | $3.89K | 0.00% |
| American Capital Advisory, LLC | 1,000 | $2.64K | 0.00% |
| Advisory Services Network, LLC | 200 | $528 | 0.00% |
| IFP Advisors, Inc | 100 | $264 | 0.00% |
| Farther Finance Advisors, LLC | 22 | $58 | 0.00% |
| Nisa Investment Advisors, LLC | 20 | $53 | 0.00% |
Sold out (6)
Institutions that held Cue Biopharma, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Sanders Morris Harris LLC | 346,212 | $713.4K |
| Simplex Trading, LLC | 22,317 | $51.0K |
| American Century Companies Inc | 21,758 | $50.0K |
| Channel Wealth LLC | 15,300 | $35.2K |
| Wolverine Trading, LLC | 11,128 | $25.6K |
| Group One Trading, L.P. | 5,278 | $12.1K |